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Abstract 
 
Background: To find out safety and efficacy of 
Misoprostol in induction of labour at term in women with 
live fetus through vaginal versus sublingual route 
Methods: In this cross sectional study, total of 200 
pregnant women at term (37-42 week) with live fetus were 
selected randomly for induction of labour with tab 
misoprostol. These women were divided in two groups 
with 100 women in each group. Misoprostol was 
administered in a dose of 50 microgram (1/4th tab),in 
group I through vaginal route and in group II through 
sublingual route. Maximum of three doses were given in 
24 hours and resumed on next day if there was no 
improvement. 
Results: Number of doses of misoprostol used for 
induction of labour was less than two in 68% cases in 
group I and 78% cases in group II, while more than two 
doses were used in 32%cases in vaginal group and 22% in 
sublingual group. Administration to induction interval 
was less than 12 hours in 60% cases in vaginal group and 
80% cases in sublingual group. Total duration of labour 
was less than 8 hours, seen in more cases of sublingual 
group than vaginal group i.e56% versus 40%. Vaginal 
delivery was achieved in 60% cases in vaginal group and 
70%cases in sublingual group with rate of caesarean 
section 40% versus 30% respectively. Regarding fetal 
outcome, fetal distress and meconium stained liquor was 
seen in 26% and 24% cases in vaginal and sublingual 
groups respectively, showing no significant difference 
between two groups. However neonatal intensive care 
unit(NICU) admissions were more in vaginal group than 
sublingual group i.e. 30% versus 20%.There were 100% 
live births in both groups with ENND (early neonatal 
death)02% in each group. Maternal out come was good in 
both groups. Uterine hyperstimulation was seen in 
02%cases in each group while only two cases of fever were 
seen in sublingual group. There was no case of post 
partum haemorrhage (PPH) and no maternal death in both 
groups.. 
Conclusion:  Misoprostol is effective for induction of 
labour at term with live fetus, more through sublingual 
than vaginal route. Its safety and efficacy can be further 
ensured by using lower dosage regimes. . 
Key words: Misoprostol, Induction of labor, Live fetus, 
maternal out come, Fetal outcome      
 
Introduction 
 
Induction of labour is the artificial initiation of 
uterine contractions prior to their spontaneous onset 
leading to progressive dilatation, effacement of the 
cervix and delivery of the baby. The purpose of 
induction is to achieve benefit to the health of mother 
and/or  baby, greater than if the pregnancy continues1 
.  The use of agents to ripen cervix prior to 
conventional methods of induction is the standard 
practice. Prostaglandins are most frequently used for 
ripening the cervix and induction of labour. Extra 
amniotic prostaglandinE2 gel or vaginal pessary are 
currently the agents of choice, but are costly2,3,4 . A 
more affordable alternative, is to use misoprostol, for 
induction of labour .Misoprostol is a synthetic 
analogue of naturally occurring prostaglandinE1 
originally manufactured for treatment of peptic ulcer. 
Misoprostol is an effective drug for ripening the cervix 
and induction of labour. Misoprostol tablets can  be 
given orally or vaginally, but  is not yet licensed for 
use in pregnancy.  Misoprostol has also shown 
usefulness in many other obstetrical and 
gynaecological problems, but nevertheless the 
company, which holds the patent rights for 
misoprostol has so far never applied for approval for 
obstetrics. However the data on optimal regimens and 
safety are lacking5-10. 
This study was planned to find out the efficacy 
and safety of misoprostol in cervical ripening, 
induction of labour, safe maternal and fetal outcome, 
vaginal delivery and minimal caesarean section rate.  
 
Patients and Methods 
It was a cross sectional comparative study. 
During a period of one year from  Jan2006 to Dec2006, 
total of 200  obstetric cases were selected randomly  for 
induction of labour with misoprostol in Gynae/ Obs. 
Department Unit 1 Holy Family Hospital Rawalpindi 
with following selection criteria: Gestation from 37 
completed weeks onwards(Term), Pregnancies with 
live fetus and Bishop score less than 5. 
Exclusion criteria were Intrauterine deaths (IUD)s, 
Multiple pregnancies, Non-vertex presentation, 
Abnormal fetal heart rate, Previous scar and Preterm 
babies. 
Ethical approval for use of misoprostol was 
obtained from Ethical Committee of the hospital. 
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Informed consent was taken from all patients included 
in this study.  
We used 50 microgram dose (1/4th tab) of 
misoprostol in both groups. In group I, the dose was 
given through vaginal route and  in group II through 
sublingual route. The dose was repeated 06 hourly. 
Maximum of three doses were given in  24 hours and 
resumed on next day in case of no improvement. In 
patients who achieved Bishop score > 7, labour was 
augmented with syntocinon drip. Fetal heart rate and 
uterine contractions were monitored at regular 
intervals. When cervix dilated 3cm, artificial rupture of 
membranes was done. Uterine hypertonus was 
defined as single uterine contraction lasting for ≥ 2 
min, tachysystole as ≥6 uterine contractions in 10 min, 
and hyper stimulation as either hypertonus or 
tachysystole associated with an abnormal fetal heart 
rate pattern. Data collected through proformas was 
entered in computer and analyzed using SPSS.  
Efficacy of misoprostol was judged by change 
of Bishop score, vaginal delivery rate in 24 hours, 
doses of misoprostol needed to induce delivery, 
caesarean section rate, fetal distress, maternal side 
effects and fetal outcome parameters.  
 
Results 
The results showed that in group I, there were 
48 primigravidae and 52 multigravida. In group II, 
there were 54 primigravidae and 46 multigravida 
(table 1). The average age was 25±5 years. Number of 
doses used for induction of labour in group I(vaginal) 
were<2  in 68% cases and >2 in 32% cases. In group II 
(sublingual), < 2 doses were used in 78% cases and >2 
doses in 22% cases (Table 1). Administration to 
induction interval in group I was <12 hours  in 60% 
cases and >12hours in 22% cases with failed induction 
seen in 18%cases.while in group II administration to 
induction interval was <12 hours in 80% cases and 
>12hours in only 08% cases with failed induction seen 
in 12% cases(Table 2).  Total duration of labour was 
less than 08 hours in 40% cases of vaginal group and 
56% cases of sublingual group.Vaginal delivery was 
achieved in 60% of vaginal group and 70% cases of 
sublingual group.(Table 3).  
Regarding fetal outcome ,fetal distress with 
meconium stained liquor was seen in 26% cases of 
vaginal group and 24% cases of sublingual group, 
showing no significant difference between two groups. 
The live birth rate was 100% in both groups. Although 
admissions in NICU were 18% in group I and 20% in 
group II, there were only 02 ENND in each 
group(Table 4).  
Regarding maternal out come uterine 
hyperstimulation was seen in 02% cases in each group. 
There was no case of fever in group I, while it was 
seen in 02 cases in group II .There was no case of PPH 
and no maternal death in both groups 
 
Table 1: Comparison of Obstetrical 
Findings  
Obstetrical 
findings 
Vaginal 
group(I) 
Sublingual  
group (II) 
Number of 
primigravida 
48 54 
Number of 
multigravida 
52 46 
Less than two 
doses used 
68% 78% 
More than two 
doses used 
32% 22% 
 
Table2: Administration To Induction 
Interval 
Duration in hours Vaginal 
group I 
Sublingual 
group II 
Less than 12 60% 80% 
More than 12 22% 08% 
Failed induction 18% 12% 
 
Table 3: Comparison of Mode Of Delivery  
Mode of delivery Vaginal 
group(1) 
Sublingual 
group (II) 
Vaginal Delivery  60 % 70% 
Caesarean Section  40 % 30% 
   Fetal Distress  32 % 12 % 
 Failed Induction  8 % 28 % 
 
Table 4: Comparison of Fetal Out Come  
Fetal out 
come 
Vaginal 
group(1) 
Sublingual group 
(ii) 
Fetal distress  26 % 24 % 
Meconium 
Passage  
26 % 24 % 
Still birth  0 % 0 % 
* NICU 
Admission  
18 % 20 % 
* NICU: Neonatal Intensive Care Unit 
 
Discussion 
 
Pakistan is an underdeveloped country with 
low socio-economic condition. In different hospitals in 
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this country, prostaglandins are used for ripening and 
dilatation of cervix. Our study shows that a synthetic 
prostaglandin analogue misoprostol is effective for 
induction of labour. Neto et al in 1987 in Brazil 
presented their first report on misoprostol induced 
vaginal delivery11-14. Since then many studies have 
suggested that per vaginal use of misoprostol is 
helpful for labour induction in unfavourable cervix. 
More than 45 randomised trials including more than 
5400 women have found vaginal misoprostol to be 
more effective than oxytocin or vaginal prostaglandin 
E2 at effecting vaginal delivery within 24 hours15-17. 
Our study shows that misoprostol is more 
effective when given by sublingual route than vaginal 
route .Similar results were found by Nahar that 
sublingual route reduced number of doses needed to 
induce labour. More women in vaginal group did not 
achieve vaginal delivery within 24 hours (38% versus 
30%). More women in the sublingual group achieved 
vaginal delivery within 08 hours of randomization 
(56%) compared with 40% in the vaginal group. The 
caesarean section (LSCS) rate was lower in sublingual 
group (30%) compared with 40% in the vaginal group. 
However, Kelly and Alisa found same rate of C-
section in both groups18,19. The reason may be the 
different dosage regime in these studies. 
Regarding fetal distress, there was no 
significant difference between two groups in our study 
(26% versus 24%).It can be further reduced by 
reducing dose of administration of misoprostol. 
An interesting result of our study is that there 
was no still birth and only 02 ENND in each group. 
The cause of ENND found was hypothermia in one 
case. In other case, it was associated with uterine 
hyperstimulation. This again addresses the need of 
evaluating safe dosage regime of misoprostol. 
Maternal outcome was good in both groups. Uterine 
hyperstimulation was seen in 02% cases in each group. 
Cocharene review 2004 by Alfirenic showed 
that vaginal route is associated with more risk of 
hyperstimulation 18.Our study shows that maternal 
side effects like fever was more in sublingual group. 
The reason may be the more systemic side effects seen 
with this route. Other studies also found that vaginal 
misoprostol is well tolerated with less systemic side 
effects19,20.  
 
Conclusion 
Misoprostol is effective for induction of labour 
at term with live fetus ,more through sublingual route 
than vaginal route .Its safety and efficacy  can be 
further ensured by using lower dosage regimes. More 
studies are required to determine safe and optimal 
dosage of misoprostol for induction of labour. 
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